The National Institute of Pharmacy and Nutrition (OGYÉI) said on Wednesday that Russia’s Sputnik V coronavirus vaccine had been approved in Hungary after establishing that it was effective and safe and the National Public Health Centre (NNK) would be checking every shipment of the vaccine separately.
OGYÉI said commenting on several recent press reports regarding Sputnik V that the institute issued its temporary, emergency approval after two months of assessments and visits to the production facility which it described as a modern and well-equipped plant where the quality of products is guaranteed. The representatives of the institute received reassuring answers to all questions raised in connection with the production of the vaccine, it added.
The safety of the vaccine is also guaranteed by the fact that the licence has been issued on condition that NNK laboratory testing is carried out for a period of around three weeks, it said.
“The vaccine can only be used in Hungary if the laboratory tests confirm that it is of acceptable quality,”
the institute said. In order to ensure the same quality for every shipment, each consignment will be tested separately by NNK, it added.
OGYÉI said it will continue monitoring the effectiveness and safety of the vaccine even after its temporary approval.
- Opposition seeks to convene extraordinary parlt session for the measures and Chinese vaccine
- Hungary purchasing enough Russian vaccine to inoculate one million
- AstraZeneca, Sputnik V vaccines get Hungarian authorities’ approval